NCT01174459已完成不适用
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 571
- 试验地点
- 159
- 主要终点
- Incidence of Drug-related Adverse Events
研究概览
简要总结
The survey is conducted to investigate the safety and efficacy of long-term use of BI-Sifrol Tablets in Restless Legs Syndrome (RLS) patients with or without renal dysfunction in routine medical practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 15 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Incidence of Drug-related Adverse Events
时间窗: 12 Months
Number of patients with drug-related adverse events
次要结局
- Change From Baseline in Total Score of the International Restless Legs Syndrome Rating Scale (IRLS)(after 12 months or at the end of observation)
研究者
研究点 (159)
Loading locations...
相似试验
已完成
不适用
Special Survey on PD Patients With Renal DysfunctionParkinson DiseaseNCT00613756Boehringer Ingelheim107
已完成
不适用
Survey on PD Patients With Depressive SymptomsParkinson DiseaseNCT00614575Boehringer Ingelheim1,089
已完成
3 期
Long-term Administration Study of SND 919 Tablets in Parkinson's DiseaseParkinson DiseaseNCT00274131Boehringer Ingelheim170
Unknown
不适用
Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary LesionsCoronary DiseaseNCT00552656Xijing Hospital1,000
已完成
不适用
Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney DiseaseChronic Kidney DiseaseNCT02805348Astellas Pharma Inc144